寒喘祖帕颗粒辅助治疗小儿哮喘发作期临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R725.6

基金项目:


Clinical Study on Hanchuan Zupa Granules in Adjuvant Therapy of Infantile Asthma at Attacking Stage
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察寒喘祖帕颗粒辅助治疗小儿哮喘发作期的临床疗效。方法:将110 例风寒束肺证患儿随机分为对照组和观察组各55 例,2 组患儿均予硫酸特布他林气雾剂治疗,重度患儿或有低氧血症者给予鼻导管或面罩吸氧,喷雾吸入不能控制病情的患儿及重度患儿,予醋酸泼尼松片、硫酸沙丁胺醇注射液治疗,疗程为3~5 d。观察组加予寒喘祖帕颗粒治疗,疗程为7 d。7 d 疗程结束后4 周应用儿童哮喘控制测试(C-ACT) 评价哮喘控制情况;治疗前、治疗7 d 后测量肺功能,记录第1 秒用力呼气量(FEV1)、第1 秒用力呼气量占用力肺活量的百分比(FEV1/FVC)、PEF 占正常预计值的百分比(PEF%)、PEF 日间变异率等,评定风寒束肺证评分。比较2 组的临床疗效与中医证候疗效,评估用药安全性。结果:治疗后,观察组临床疗效、中医证候疗效、哮喘控制情况均优于对照组,差异均有统计学意义(P<0.05)。2 组FEV1、FEV1/FVC 及PEF%均较治疗前增加,PEF日间变异率均较治疗前减少,差异均有统计学意义(P<0.01);观察组FEV1、FEV1/FVC 及PEF%均高于对照组,PEF 日间变异率小于对照组,差异均有统计学意义(P<0.01)。治疗期间,2 组患儿均未发生严重不良反应。血常规、心电图、肝功能、肾功能检查未出现明显与药物相关的不良反应,未发现与寒喘祖帕颗粒使用相关的不良反应。结论:在现代医学常规治疗的基础上加用寒喘祖帕颗粒,可进一步控制小儿哮喘发作期的症状,哮喘控制效果确切,用药安全性较好。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Hanchuan Zupa granules in adjuvant therapy of infantile asthma at attacking stage. Methods: A total of 110 cases of children with syndrome of wind- cold fettering the lung were randomly divided into the control group and the observation group,55 cases in each group. Both groups were given terbutaline sulfate aerosol;for severe patients or patients with hypoxemia,they were given nasal cannula or oxygen mask;for severe patients and patients whose condition could not be controlled through spray inhalation,they were given prednisone acetate tablets and salbutamol sulfate injection. The course of both groups ranged from three to five days. The observation group was additionally given Hanchuan Zupa granules,and treated for seven days. Four weeks after seven-day treatment,the control of asthma was evaluated through Children's Asthma Control Test(C-ACT). Before treatment and after seven-day treatment, the lung function was measured;forced expiratory volume in one second(FEV1),the ratio of forced expiratory volume in one second to forced vital capacity(FEV1/FVC), the percentage of peak expiratory flow in estimated value(PEF% ), the rate of diurnal variation in PEF and so on were recorded;the score of syndrome of wind-cold fettering the lung was evaluated. The clinical effect and the curative effect of Chinese medicine syndromes were compared between the two groups. The medication safety was evaluated. Results: After treatment, the clinical effect, the curative effect of Chinese medicine syndromes,and the control of asthma was better than that in the control group,differences being significant(P<0.05). The indexes of FEV1,FEV1/FVC,and PEF% in the two groups were increased when compared with those before treatment,and the rate of diurnal variation in PEF was decreased,differences being significant(P<0.01). The indexes of FEV1,FEV1/FVC, and PEF% in the observation group were higher than those in the control group,and the rate of diurnal variation in PEF was lower, differences being significant(P<0.01). During treatment, no severe adverse reactions occurred in the two groups. According to the results of blood routine examination, electrocardiogram, and the examination of the lung and the kidney function,there was no adverse reactions evidently related to medicine or the use of Hanchuan Zupa granules. Conclusion: Based on routine therapy of modern medicine,the additional Hanchuan Zupa granules can further control the symptoms of infantile asthma at attacking stage,and has defined control effect of asthma and good medication safety.

    参考文献
    相似文献
    引证文献
引用本文

聂凤艳.寒喘祖帕颗粒辅助治疗小儿哮喘发作期临床研究[J].新中医,2021,53(2):69-73

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-01-27
  • 出版日期:
文章二维码